FDA Inspection
Hangzhou Huadong Medicine Group Zhejiang Huayi Pharmaceutical Co., LTD.Hangzhou Huadong Medicine Group Zhejiang Huayi Pharmaceutical Co., LTD. – FDA Inspection, Mar 16, 2018
Record Details
This FDA Inspection record concerns Hangzhou Huadong Medicine Group Zhejiang Huayi Pharmaceutical Co., LTD., with an inspection on March 16, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 16, 2018
- Product Type
- Drugs
View Company Profile
ID · 4651a11d-4232-48f5-840a-c7112616b42b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1050113
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Hangzhou Huadong Medicine Group Zhejiang Huayi Pharmaceutical Co., LTD.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 18, 2025 | Not classified | Office of Inspections and Investigations | |
| April 3, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 30, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hangzhou Huadong Medicine Group Zhejiang Huayi Pharmaceutical Co., LTD.
- FDA Inspection 1270219 - 2025-04-18
- FDA Inspection 926970 - 2015-04-03
- FDA Inspection 706890 - 2010-10-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.